CDR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.291200E-01
Normal-vs-Stage2
4.008000E-01
Normal-vs-Stage3
9.990600E-01
Normal-vs-Stage4
8.955600E-02
Stage1-vs-Stage2
2.758600E-01
Stage1-vs-Stage3
9.330200E-01
Stage1-vs-Stage4
3.348200E-02
Stage2-vs-Stage3
3.338400E-01
Stage2-vs-Stage4
6.479700E-02
Stage3-vs-Stage4
7.605800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.966600E-01
Normal-vs-AfricanAmerican
1.705610E-01
Normal-vs-Asian
7.998400E-01
Caucasian-vs-AfricanAmerican
9.919600E-02
Caucasian-vs-Asian
4.858600E-01
AfricanAmerican-vs-Asian
1.346970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.746000E-01
Normal-vs-Female
4.825000E-01
Male-vs-Female
6.038000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.826400E-01
Normal-vs-Age(41-60Yrs)
2.375800E-01
Normal-vs-Age(61-80Yrs)
5.746200E-01
Normal-vs-Age(81-100Yrs)
9.702000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.398400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.866600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.976800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.342100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.182400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.426400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.862400E-01
Normal-vs-Daily Drinker
9.138600E-01
Normal-vs-Weekly Drinker
3.887800E-01
Normal-vs-Occasional Drinker
9.127600E-01
Normal-vs-Social Drinker
2.589600E-01
Non Drinker-vs-Daily Drinker
1.737020E-01
Non Drinker-vs-Weekly Drinker
2.863600E-01
Non Drinker-vs-Occasional Drinker
4.020800E-01
Non Drinker-vs-Social Drinker
1.439220E-01
Daily Drinker-vs-Weekly Drinker
4.332000E-02
Daily Drinker-vs-Occasional Drinker
6.816400E-01
Daily Drinker-vs-Social Drinker
1.788420E-02
Weekly Drinker-vs-Occasional Drinker
1.085800E-01
Weekly Drinker-vs-Social Drinker
9.966600E-01
Occasional Drinker-vs-Social Drinker
5.717900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.889600E-01
Normal-vs-Grade 2
1.763570E-02
Normal-vs-Grade 3
7.235800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.090100E-02
Grade 1-vs-Grade 3
8.868300E-02
Grade 1-vs-Grade 4
2.889600E-01
Grade 2-vs-Grade 3
7.486400E-01
Grade 2-vs-Grade 4
1.763570E-02
Grade 3-vs-Grade 4
7.235800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.184600E-01
Normal-vs-NonDiabetic
5.349400E-01
Diabetic-vs-NonDiabetic
9.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.643800E-01
Normal-vs-NoPancreatitis
5.742600E-01
Pancreatitis-vs-NoPancreatitis
1.330360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.118200E-01
Normal-vs-N1
3.946200E-01
N0-vs-N1
2.252800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.333000E-01
Normal-vs-TP53-NonMutant
5.909000E-01
TP53-Mutant-vs-TP53-NonMutant
1.627970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
